269 related articles for article (PubMed ID: 27856317)
1. Drug delivery by erythrocytes: "Primum non nocere".
Villa CH; Seghatchian J; Muzykantov V
Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
[TBL] [Abstract][Full Text] [Related]
2. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
Pan D; Vargas-Morales O; Zern B; Anselmo AC; Gupta V; Zakrewsky M; Mitragotri S; Muzykantov V
PLoS One; 2016; 11(3):e0152074. PubMed ID: 27003833
[TBL] [Abstract][Full Text] [Related]
4. Red Blood Cells as Smart Delivery Systems.
Han X; Wang C; Liu Z
Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
[TBL] [Abstract][Full Text] [Related]
5. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
[TBL] [Abstract][Full Text] [Related]
6. Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.
Villa CH; Cines DB; Siegel DL; Muzykantov V
Transfus Med Rev; 2017 Jan; 31(1):26-35. PubMed ID: 27707522
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
Bhateria M; Rachumallu R; Singh R; Bhatta RS
Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery by red blood cells: vascular carriers designed by mother nature.
Muzykantov VR
Expert Opin Drug Deliv; 2010 Apr; 7(4):403-27. PubMed ID: 20192900
[TBL] [Abstract][Full Text] [Related]
9. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery.
Izzati Mat Rani NN; Alzubaidi ZM; Azhari H; Mustapa F; Iqbal Mohd Amin MC
Eur J Pharmacol; 2021 Jun; 900():174009. PubMed ID: 33722591
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Biocompatibility Characterization of Red Blood Cell Membrane Targeted and Cell-Penetrating-Peptide-Modified Polymeric Nanoparticles.
Sahoo K; Karumuri S; Hikkaduwa Koralege RS; Flynn NH; Hartson S; Liu J; Ramsey JD; Kalkan AK; Pope C; Ranjan A
Mol Pharm; 2017 Jul; 14(7):2224-2235. PubMed ID: 28505457
[TBL] [Abstract][Full Text] [Related]
11. Clinical progress and advanced research of red blood cells based drug delivery system.
Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M; Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M
Biomaterials; 2021 Dec; 279():121202. PubMed ID: 34749072
[TBL] [Abstract][Full Text] [Related]
12. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-inspired delivery systems.
Hu CM; Fang RH; Zhang L
Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
[TBL] [Abstract][Full Text] [Related]
14. Erythrocytes as carriers of immunoglobulin-based therapeutics.
Ji W; Smith PN; Koepsel RR; Andersen JD; Baker SL; Zhang L; Carmali S; Myerson JW; Muzykantov V; Russell AJ
Acta Biomater; 2020 Jan; 101():422-435. PubMed ID: 31669698
[TBL] [Abstract][Full Text] [Related]
15. Surface-modified loaded human red blood cells for targeting and delivery of drugs.
Sternberg N; Georgieva R; Duft K; Bäumler H
J Microencapsul; 2012; 29(1):9-20. PubMed ID: 22034952
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte-based drug delivery in Transfusion Medicine: Wandering questions seeking answers.
Tzounakas VL; Karadimas DG; Papassideri IS; Seghatchian J; Antonelou MH
Transfus Apher Sci; 2017 Aug; 56(4):626-634. PubMed ID: 28774826
[TBL] [Abstract][Full Text] [Related]
17. Drug-loaded erythrocytes: Modern approaches for advanced drug delivery for clinical use.
Berikkhanova K; Taigulov E; Bokebaev Z; Kusainov A; Tanysheva G; Yedrissov A; Seredin G; Baltabayeva T; Zhumadilov Z
Heliyon; 2024 Jan; 10(1):e23451. PubMed ID: 38192824
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides as a novel transdermal drug delivery system.
Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
[TBL] [Abstract][Full Text] [Related]
19. Erythrocytes as carriers for recombinant human erythropoietin.
Garín MI; López RM; Sanz S; Pinilla M; Luque J
Pharm Res; 1996 Jun; 13(6):869-74. PubMed ID: 8792424
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery carriers on the fringes: natural red blood cells versus synthetic multilayered capsules.
Muzykantov VR
Expert Opin Drug Deliv; 2013 Jan; 10(1):1-4. PubMed ID: 23176316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
